Jennifer Lachey Ph.D.
Net Worth

Last updated:

What is Jennifer Lachey Ph.D. net worth?

The estimated net worth of Dr. Jennifer Lachey Ph.D. is at least $9,426,138 as of 15 Jul 2022. He owns shares worth $1,378,950 as insider, has earned $5,947,508 from insider trading and has received compensation worth at least $2,099,680 in Keros Therapeutics, Inc..

What is the salary of Jennifer Lachey Ph.D.?

Dr. Jennifer Lachey Ph.D. salary is $524,920 per year as Chief Scientific Officer in Keros Therapeutics, Inc..

How old is Jennifer Lachey Ph.D.?

Dr. Jennifer Lachey Ph.D. is 53 years old, born in 1972.

What stocks does Jennifer Lachey Ph.D. currently own?

As insider, Dr. Jennifer Lachey Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Keros Therapeutics, Inc. (KROS) Chief Scientific Officer 95,100 $14.5 $1,378,950

What does Keros Therapeutics, Inc. do?

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

KROS logo
KROS
Keros Therapeutics, Inc.
$14.5

Jennifer Lachey Ph.D. insider trading

Keros Therapeutics, Inc.

Dr. Jennifer Lachey Ph.D. has made 31 insider trades between 2021-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 46,034 units of KROS stock on 15 Jul 2022. As of 15 Jul 2022 he still owns at least 95,100 units of KROS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Option (right to buy) 46,034 $0.3 $13,810
Option
Common Stock 46,034 $0.3 $13,810
Sale
Common Stock 46,034 $30 $1,381,020
Option
Common Stock 1,916 $0.3 $575
Option
Employee Stock Option (right to buy) 1,916 $0.3 $575
Sale
Common Stock 1,916 $30 $57,480
Option
Employee Stock Option (right to buy) 9,400 $0.3 $2,820
Option
Common Stock 9,400 $0.3 $2,820
Sale
Common Stock 719 $43.32 $31,147
Sale
Common Stock 3,398 $41.26 $140,201
Sale
Common Stock 944 $42.49 $40,111
Option
Employee Stock Option (right to buy) 5,300 $0.3 $1,590
Sale
Common Stock 223 $44.23 $9,863
Sale
Common Stock 16 $45.45 $727
Option
Common Stock 5,300 $0.3 $1,590
Sale
Common Stock 1,009 $62.32 $62,881
Sale
Common Stock 559 $64.15 $35,860
Option
Common Stock 5,300 $0.3 $1,590
Option
Employee Stock Option (right to buy) 5,300 $0.3 $1,590
Sale
Common Stock 2,315 $63.5 $147,003
Sale
Common Stock 1,417 $61.37 $86,961
Option
Common Stock 7,950 $0.3 $2,385
Sale
Common Stock 7,950 $60 $477,000
Option
of Shares Employee Stock Option (right to buy) 7,950 $0.3 $2,385
Sale
Common Stock 1,062 $52.43 $55,681
Sale
Common Stock 713 $53.36 $38,046
Option
Employee Stock Option (right to buy) 2,650 $0.3 $795
Option
Common Stock 2,650 $0.3 $795
Sale
Common Stock 875 $54.54 $47,723
Option
Employee Stock Option (right to buy) 2,650 $0.3 $795
Sale
Common Stock 1,378 $52.35 $72,138
Option
Common Stock 2,650 $0.3 $795
Sale
Common Stock 199 $53.1 $10,567
Sale
Common Stock 1,073 $51.5 $55,260
Option
Common Stock 2,650 $0.3 $795
Option
Employee Stock Option (right to buy) 2,650 $0.3 $795
Sale
Common Stock 2,650 $53.34 $141,351
Option
Common Stock 2,650 $0.3 $795
Sale
Common Stock 2,650 $60 $159,000
Option
Employee Stock Option (right to buy) 2,650 $0.3 $795
Option
Common Stock 735 $0.3 $221
Option
Employee Stock Option (right to buy) 2,650 $0.3 $795
Sale
Common Stock 735 $50 $36,750
Option
Common Stock 1,915 $0.3 $575
Sale
Common Stock 1,915 $51.99 $99,561
Option
Employee Stock Option (right to buy) 21,200 $0.3 $6,360
Sale
Common Stock 5,300 $59.26 $314,052
Option
Common Stock 5,300 $0.3 $1,590
Option
Common Stock 15,900 $0.3 $4,770
Sale
Common Stock 15,900 $60 $954,000
Option
Common Stock 10,600 $0.3 $3,180
Option
Employee Stock Option (right to buy) 10,600 $0.3 $3,180
Sale
Common Stock 10,600 $50 $530,000
Option
Employee Stock Option (right to buy) 1,293 $0.3 $388
Option
Common Stock 1,293 $0.3 $388
Option
Employee Stock Option (right to buy) 6,500 $0.3 $1,950
Option
Common Stock 6,500 $0.3 $1,950
Option
Common Stock 2,650 $0.3 $795
Sale
Common Stock 2,650 $51.41 $136,237
Sale
Common Stock 2,650 $51.41 $136,237
Option
Employee Stock Option (right to buy) 2,650 $0.3 $795
Option
Common Stock 6,720 $0.21 $1,378
Option
Employee Stock Option (right to buy) 6,720 $0.21 $1,378
Option
Employee Stock Option (right to buy) 6,720 $0.21 $1,378
Option
Common Stock 6,720 $0.21 $1,378
Sale
Common Stock 2,650 $0.3 $795
Option
Employee Stock Option (right to buy) 2,650 $0.3 $795
Option
Common Stock 2,650 $0.3 $795
Sale
Common Stock 5,300 N/A N/A
Option
Employee Stock Option (right to buy) 5,300 $0.3 $1,590
Option
Common Stock 5,300 $0.3 $1,590
Option
Employee Stock Option (right to buy) 9,996 $0.11 $1,100
Option
Common Stock 9,996 $0.11 $1,100
Option
Common Stock 5,300 $0.3 $1,590
Sale
Common Stock 5,300 $64.73 $343,053
Option
Employee Stock Option (right to buy) 5,300 $0.3 $1,590
Option
Employee Stock Option (right to buy) 33,200 $0.11 $3,652
Option
Common Stock 33,200 $0.11 $3,652
Option
Employee Stock Option (right to buy) 5,300 $0.3 $1,590
Sale
Common Stock 5,300 $65.44 $346,806
Option
Common Stock 5,300 $0.3 $1,590

Keros Therapeutics key executives

Keros Therapeutics, Inc. executives and other stock owners filed with the SEC: